Canada Pension Plan Investment Board’s AMAG Pharmaceuticals AMAG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-10
| Closed | – | – | 1511 |
|
|
2020
Q3 | $0 | Sell |
10
-45
| -82% | -$428 | ﹤0.01% | 1451 |
|
|
2020
Q2 | $0 | Hold |
55
| – | – | ﹤0.01% | 1519 |
|
|
2020
Q1 | $0 | Hold |
55
| – | – | ﹤0.01% | 1533 |
|
|
2019
Q4 | $1K | Sell |
55
-158,925
| -100% | -$1.74M | ﹤0.01% | 1408 |
|
|
2019
Q3 | $1.84M | Buy |
158,980
+149,146
| +1,517% | +$1.57M | ﹤0.01% | 864 |
|
|
2019
Q2 | $98K | Sell |
9,834
-125,305
| -93% | -$1.35M | ﹤0.01% | 1153 |
|
|
2019
Q1 | $1.74M | Sell |
135,139
-129,761
| -49% | -$1.93M | ﹤0.01% | 1020 |
|
|
2018
Q4 | $4.02M | Buy |
264,900
+229,800
| +655% | +$4.38M | 0.01% | 830 |
|
|
2018
Q3 | $702K | Sell |
35,100
-25,700
| -42% | -$585K | ﹤0.01% | 1126 |
|
|
2018
Q2 | $1.19M | Buy |
60,800
+60,400
| +15,100% | +$1.34M | ﹤0.01% | 1049 |
|
|
2018
Q1 | $8K | Buy |
+400
| New | +$6.77K | ﹤0.01% | 1185 |
|
|
2017
Q4 | – | Sell |
-7,800
| Closed | -$144K | – | 1241 |
|
|
2017
Q3 | $144K | Sell |
7,800
-13,000
| -63% | -$242K | ﹤0.01% | 1058 |
|
|
2017
Q2 | $383K | Buy |
20,800
+18,100
| +670% | +$359K | ﹤0.01% | 1004 |
|
|
2017
Q1 | $61K | Buy |
+2,700
| New | +$64.6K | ﹤0.01% | 1078 |
|
Canada Pension Plan Investment Board's AMAG Position: Q4 2020 in Review
Canada Pension Plan Investment Board sold out of AMAG Pharmaceuticals (AMAG) in Q4 2020, closing a stake of 10 shares.
Canada Pension Plan Investment Board first reported a position in AMAG in Q1 2017 and held it in 14 quarters. The position peaked at $4.02M in Q4 2018. 1 fund tracked by Wall St. Rank holds AMAG as of Q4 2020.
- Canada Pension Plan Investment Board reported no remaining AMAG Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
- Canada Pension Plan Investment Board sold 10 AMAG Pharmaceuticals shares in Q4 2020.
- Canada Pension Plan Investment Board first reported a position in AMAG Pharmaceuticals in Q1 2017 and held it in 14 quarters.
- Canada Pension Plan Investment Board's AMAG Pharmaceuticals position peaked at $4.02M in Q4 2018.
- 1 fund tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2020.
Based on Canada Pension Plan Investment Board's 13F filing for Q4 2020, filed 17 Feb 2021.